+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength, Age Group - Global Forecast to 2030- Product Image
Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength, Age Group - Global Forecast to 2030- Product Image
Sale

Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968933
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Smoking Cessation & Nicotine De-Addiction Product Market grew from USD 30.89 billion in 2024 to USD 34.01 billion in 2025. It is expected to continue growing at a CAGR of 9.72%, reaching USD 53.93 billion by 2030.

Setting the Stage for a Smoke-Free Future

An accelerating global focus on public health and wellness has placed smoking cessation and nicotine de-addiction at the forefront of preventive medicine. The persistent burden of tobacco-related disease, alongside rising awareness of the health and economic costs associated with nicotine dependency, has created a strong imperative for innovative treatment modalities. This report delves into the multifaceted nature of the market, capturing both the traditional therapies that remain pillars of intervention and the novel solutions reshaping patient journeys. By examining behavioral counseling, pharmacological aids, and cutting-edge electronic delivery systems, readers will acquire a panoramic understanding of the forces driving market expansion and transformation.

Moreover, this introduction outlines the rationale and scope of our analysis, setting the foundation for a detailed exploration of emerging dynamics. From policy shifts to consumer preferences, our objective is to equip stakeholders with a clear lens through which to view opportunities and anticipate challenges. As the healthcare ecosystem continues to prioritize preventive strategies, the evidence-based recommendations within this document will serve as a strategic compass for manufacturers, providers, and policymakers seeking to capitalize on the momentum toward a smoke-free future.

Emergence of Breakthrough Treatment Paradigms

The smoking cessation arena is experiencing a profound metamorphosis, driven by advancements in digital health, personalized medicine, and regulatory frameworks. Recent breakthroughs in behavioral analytics have enabled precision counseling that tailors support to individual readiness and relapse risk, elevating quit rates and patient satisfaction. Simultaneously, the rapid proliferation of e-cigarette technologies has prompted rigorous debates around safety, efficacy, and long-term public health implications, compelling regulators to adopt nuanced policies that balance harm reduction with youth protection.

In parallel, breakthroughs in pharmacogenomics have illuminated genetic markers associated with nicotine metabolism, paving the way for targeted prescription therapies that maximize efficacy while minimizing adverse reactions. Cross-functional partnerships between biotech firms and academic institutions have accelerated clinical trials of emerging compounds, signaling a shift toward next-generation de-addiction drugs. Collectively, these transformative shifts underscore a dynamic landscape in which innovation, policy, and patient-centric design converge to redefine cessation pathways.

Navigating the 2025 US Tariff Landscape

The introduction of new tariff measures in the United States during 2025 has recalibrated cost structures for imported smoking cessation and nicotine replacement products, affecting supply chains and competitive positioning. Increased duties on electronic device components and active pharmaceutical ingredients have prompted suppliers to reevaluate sourcing strategies and consider nearshoring of manufacturing to mitigate margin erosion. This environment has catalyzed negotiations between manufacturers and local producers to establish more resilient, cost-effective partnerships that can withstand future trade disruptions.

Furthermore, domestic producers have leveraged these tariff-induced challenges as an opportunity to differentiate their offerings based on quality, regulatory compliance, and supply chain transparency. Pharmaceutical companies with integrated manufacturing capabilities have gained a strategic edge, streamlining operations to absorb levy pressures without compromising affordability. As a result, market dynamics are shifting toward a hybrid model in which global innovation is complemented by localized production excellence, fostering a more agile and responsive ecosystem.

Holistic Segmentation Reveals Diverse Opportunities

A granular examination of product categories reveals nuanced growth trajectories across behavioral therapy, electronic systems, nicotine replacement aids, and prescription medications. Behavioral therapy, segmented into group counseling and individual counseling, continues to garner attention for its holistic approach, blending cognitive restructuring with peer support to address psychosocial drivers of addiction. Electronic delivery systems are differentiated by closed systems that offer proprietary formulations and open systems that enable user customization, each catering to distinct consumer preferences and regulatory environments.

Within nicotine replacement therapies, gum, inhalers, lozenges, nasal sprays, and patches present diverse user experiences, ranging from discreet sip-and-chew formats to transdermal administration that provides sustained release. Prescription drugs such as bupropion, cytisine, and varenicline maintain clinical prominence by targeting neurochemical pathways associated with craving and withdrawal. Distinct routes of administration further diversify treatment efficacy and patient adherence. Inhalation methods, including inhaler devices and nasal spray formats, yield rapid onset effects, while oral ingestion through gum, lozenges, and tablets balances convenience with controlled dosing. Transdermal patches offer steady-state delivery, minimizing peak-trough fluctuations and supporting continuous exposure.

Distribution channel analysis highlights the strategic interplay between hospital settings, online platforms, pharmacy outlets, and retail environments. Convenience stores, specialty stores, and supermarkets under the retail umbrella offer varied access points, reflecting consumer demand for immediacy and convenience. End users span adolescents navigating early use prevention, adults engaging in cessation programs, heavy smokers requiring intensified support, and pregnant women seeking safe pathways to protect maternal and fetal health. Nicotine strength choices-ranging from low to medium to high concentrations-empower individuals to tailor their tapering process, while age group distinctions among adult, senior, and youth cohorts guide messaging, safety protocols, and regulatory compliance. This comprehensive segmentation underscores the market’s complexity and the imperative for bespoke strategies across therapeutic interventions, access channels, and demographic cohorts.

Regional Dynamics Shaping Market Growth

Regional dynamics play a pivotal role in shaping both demand and innovation trajectories. In the Americas, a convergence of public health campaigns, insurance reimbursement initiatives, and digital health adoption has spurred demand for integrated cessation programs, combining tech-enabled coaching with pharmacological support. Regulatory bodies in North and South America are harmonizing guidelines to ensure consistent product safety standards, creating an environment where multinational and local brands can thrive under a unified framework.

Across Europe, the Middle East and Africa, regulatory heterogeneity persists yet offers fertile ground for market entrants equipped with robust clinical data and adaptable distribution strategies. Western Europe’s stringent product approval processes coexist with emerging markets in the Middle East and Africa that value cost-effectiveness and rapid deployment. Collaborative efforts between governments and private-sector entities have begun to standardize reporting requirements, paving the way for scalable rollout of both traditional and novel cessation therapies.

In the Asia-Pacific region, a youthful population base and accelerating digital infrastructure have amplified interest in e-cigarette alternatives and mobile health applications. Governments in key economies are testing regulatory models that distinguish between combustible tobacco, harm-reduction devices, and medicinal therapies. As digital literacy and online pharmacy penetration deepen, stakeholders are capitalizing on omnichannel approaches to reach diverse consumer segments.

Competitive Landscape and Strategic Positioning

The competitive landscape is characterized by a blend of established pharmaceutical players, specialized biotech innovators, and nimble digital health startups. Legacy firms leverage extensive clinical trial expertise and established distribution networks to maintain leadership in prescription and over-the-counter nicotine replacement therapies. At the same time, emerging digital therapeutics companies harness artificial intelligence, machine learning, and behavioral science to deliver personalized cessation support through smartphone applications and remote coaching platforms.

Strategic collaborations and acquisitions are commonplace as organizations strive to expand their portfolios and gain footholds in adjacent segments. Partnerships between device manufacturers and research institutes have accelerated the development of next-generation e-cigarette systems with enhanced safety features and user-friendly interfaces. Meanwhile, pharmaceutical companies are integrating digital adherence tools into their offerings to bolster patient outcomes and differentiate brands. This confluence of technology and traditional pharmacology is redefining competitive moats and compelling market participants to rethink channels to market, pricing strategies, and R&D roadmaps.

Strategic Imperatives for Market Leadership

Industry leaders should prioritize integrated development roadmaps that marry clinical rigor with digital engagement frameworks. Embracing modular product architectures can enable rapid iteration of device components in response to regulatory feedback and consumer insights. Differentiation through personalized experience design-such as tailoring nicotine strength transitions based on real-time adherence data-will foster stronger patient loyalty and improved cessation outcomes.

Investment in regional manufacturing partnerships will be critical to hedge against future trade policy shifts while accelerating local market entry. Establishing centers of excellence for outcome measurement can build evidence repositories that support reimbursement discussions and facilitate cross-market regulatory approvals. To capture the next wave of growth, executives should also explore blended care models that integrate group and individual counseling services with pharmacological and technological solutions, creating seamless end-to-end treatment journeys.

Rigorous Approach Underpinning Our Findings

This research employed a multi-phased approach combining primary interviews with industry veterans, clinicians, and policy experts alongside secondary analysis of regulatory filings, patent databases, and peer-reviewed literature. A rigorous vetting process ensured the inclusion of only high-fidelity data sources, with triangulation methods applied to reconcile any discrepancies among qualitative and quantitative insights.

Market segmentation was derived through an iterative framework that mapped product attributes, route of administration profiles, distribution channel dynamics, and demographic characteristics. Geographic coverage encompassed the Americas, Europe, the Middle East and Africa, and Asia-Pacific, with emphasis on regulatory ecosystems and consumer behavior patterns unique to each region. Competitive benchmarking involved SWOT analyses of key players, patent landscaping, and scenario planning to anticipate potential disruptions. The resulting synthesis offers a robust, holistic view of current market realities and future inflection points.

Synthesis of Key Takeaways

The collective insights presented herein crystallize the converging forces of technological innovation, policy reform, and evolving consumer expectations that are redefining the smoking cessation and nicotine de-addiction market. From granular segmentation nuances to high-impact tariff influences, the analysis underscores the imperative for agile strategies and evidence-based decision-making. Stakeholders who internalize these themes and act decisively will be best positioned to capture value, drive meaningful health outcomes, and shape the trajectory toward a smoke-free world.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Behavioral Therapy
      • Group Counseling
      • Individual Counseling
    • E Cigarettes
      • Closed System
      • Open System
    • Nicotine Replacement Therapies
      • Gum
      • Inhalers
      • Lozenges
      • Nasal Spray
      • Patch
    • Prescription Drugs
      • Bupropion
      • Cytisine
      • Varenicline
  • Route Of Administration
    • Inhalation
      • Inhaler
      • Nasal Spray
    • Oral
      • Gum
      • Lozenge
      • Tablet
    • Sublingual
    • Transdermal
      • Patch
  • Distribution Channel
    • Hospital
    • Online
    • Pharmacy
    • Retail Stores
      • Convenience Store
      • Specialty Store
      • Supermarket
  • End User
    • Adolescents
    • Adults
    • Heavy Smokers
    • Pregnant Women
  • Nicotine Strength
    • High
    • Low
    • Medium
  • Age Group
    • Adult
    • Senior
    • Youth
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Sanofi S.A.
  • Viatris Inc.
  • Cipla Limited
  • Zambon S.p.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Smoking Cessation & Nicotine De-Addiction Product Market, by Product Type
8.1. Introduction
8.2. Behavioral Therapy
8.2.1. Group Counseling
8.2.2. Individual Counseling
8.3. E Cigarettes
8.3.1. Closed System
8.3.2. Open System
8.4. Nicotine Replacement Therapies
8.4.1. Gum
8.4.2. Inhalers
8.4.3. Lozenges
8.4.4. Nasal Spray
8.4.5. Patch
8.5. Prescription Drugs
8.5.1. Bupropion
8.5.2. Cytisine
8.5.3. Varenicline
9. Smoking Cessation & Nicotine De-Addiction Product Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.2.1. Inhaler
9.2.2. Nasal Spray
9.3. Oral
9.3.1. Gum
9.3.2. Lozenge
9.3.3. Tablet
9.4. Sublingual
9.5. Transdermal
9.5.1. Patch
10. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution Channel
10.1. Introduction
10.2. Hospital
10.3. Online
10.4. Pharmacy
10.5. Retail Stores
10.5.1. Convenience Store
10.5.2. Specialty Store
10.5.3. Supermarket
11. Smoking Cessation & Nicotine De-Addiction Product Market, by End User
11.1. Introduction
11.2. Adolescents
11.3. Adults
11.4. Heavy Smokers
11.5. Pregnant Women
12. Smoking Cessation & Nicotine De-Addiction Product Market, by Nicotine Strength
12.1. Introduction
12.2. High
12.3. Low
12.4. Medium
13. Smoking Cessation & Nicotine De-Addiction Product Market, by Age Group
13.1. Introduction
13.2. Adult
13.3. Senior
13.4. Youth
14. Americas Smoking Cessation & Nicotine De-Addiction Product Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. GlaxoSmithKline plc
17.3.3. Pfizer Inc.
17.3.4. Novartis AG
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Perrigo Company plc
17.3.7. Sanofi S.A.
17.3.8. Viatris Inc.
17.3.9. Cipla Limited
17.3.10. Zambon S.p.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET MULTI-CURRENCY
FIGURE 2. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET MULTI-LANGUAGE
FIGURE 3. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GROUP COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INDIVIDUAL COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CYTISINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY VARENICLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY GUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY LOZENGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CONVENIENCE STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SPECIALTY STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SUPERMARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HEAVY SMOKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PREGNANT WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HIGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY LOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY SENIOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY YOUTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 95. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 96. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 97. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 98. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 101. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 102. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 104. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 106. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 120. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 180. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 182. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 183. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 187. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 189. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 191. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 194. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 195. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 196. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 199. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 200. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 203. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 205. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 222. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 223. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 224. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 225. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 228. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 229. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 231. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 233. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 236. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 237. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 238. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 239. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 241. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 243. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL STORES, 2018-2030 (USD MILLION)
TABLE 245. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE STRENGTH, 2018-2030 (USD MILLION)
TABLE 247. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E CIGARETTES, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL

Companies Mentioned

The companies profiled in this Smoking Cessation & Nicotine De-Addiction Product market report include:
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Sanofi S.A.
  • Viatris Inc.
  • Cipla Limited
  • Zambon S.p.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 34.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 53.93 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report By Type (Nicotine Replacement Therapy), By Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Smoking Cessation and Nicotine De-Addiction Products Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Smoking Cessation and Nicotine De-Addiction Products Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Smoking Cessation and Nicotine De-Addiction Products - Global Strategic Business Report - Product Image

Smoking Cessation and Nicotine De-Addiction Products - Global Strategic Business Report

  • Report
  • 114 Pages
  • Global
From
Smoking Cessation and Nicotine De-Addiction Products Market Report 2025 - Product Image

Smoking Cessation and Nicotine De-Addiction Products Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Smoking Cessation and Nicotine De-addiction Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Smoking Cessation and Nicotine De-addiction Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.